drugset

drugset / Trial / NCT01412177

OTO-104 for the Treatment of Meniere's Disease

NCT01412177 ↗

Phase 2 Completed 154 enrolled Otonomy, Inc.

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.

Timeline

Start: 2013-11
Primary completion: 2015-03
Completion: 2015-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexamethasone	Small molecule	12 mg	Other

Indications